HAMBURG, GERMANY - A new study led by precision oncology pioneers Indivumed Therapeutics reveals significant changes in the molecular characteristics of tumor samples within as little as 10 minutes after surgical removal. The findings underline the importance of rapid snap freezing of tissue samples to reliably capture cancer biology and reveal novel drug targets.
This virtual course will show how public bioimaging data resources, centred around the BioImage Archive, enable and enhance machine learning based image analysis. The content will explore a variety of data types including electron and light microscopy and miscellaneous or multi-modal imaging data at the cell and tissue scale. Participants will cover contemporary biological image analysis with an emphasis on machine learning methods, as well as how to access and use images from databases.
• Programmable, tunable, stable and specific gene silencing has been demonstrated across multiple target genes and multiple cell types
• PoC achieved with concomitant silencing of more than one gene
• Industrialisation of platform processes delivering significant increase in throughput
• Strategic in-house focus on development of pipeline of programmable advanced therapies in oncology and genetic disease
Join us for a networking lunch followed by four inspiring talks from life science leaders and a wellbeing workshop.
Speakers
Steve Martin PhD, Vice President and Head, GSK
Cesare Cejas PhD, Co Founder, MFX
Andrew Stewart, Director of Communications, LifeArc
Ian Parnham PhD, Skills Programme Lead, Cell and Gene Therapy Catapult
Workshop Leads
James Kusena PhD, Vice President of Operations, MFX
Andrew Parsons PhD, Health, Wellness & Executive Coach. Emotional Freedom Techniques. Business Psychologist. Innovator. Author.
The Role:
We are seeking a dedicated EHS & Lab Assistant, Shipping & Sample Administrator to join our team onsite in Cambridge, UK, five days a week. In this dynamic role, you will provide vital support across various functions, including Environmental Health and Safety (EHS), facilities, lab operations, shipping, stockroom, and site housekeeping. You will play a key role in supporting our scientists and facilities, ensuring safety protocols are upheld, shipments are managed efficiently, and the lab environment remains organized and well-stocked.
London, September 26, 2024 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with CellCentric and is pleased to announce the placement of Andy Fergus as Chief Development Officer. Andy joined CellCentric in September 2024, and is Boston based.
PACE (Pathways to Antimicrobial Clinical Efficacy) has today launched its second funding round with up to £5 million available to support cutting-edge diagnostic projects. This funding is part of a broader £30 million investment to address the global challenge of antimicrobial resistance (AMR).
Paris, France - A new research study published in Nature Communications highlights how Depixus’ scalable single molecule technology can provide detailed mechanistic insights into RNA-ligand binding, supporting the development of novel therapeutics.
Based on magnetic force spectroscopy (MFS), Depixus’ large scale interactomics platform is the first analytical technology capable of exploring dynamic biomolecular interactions both in real time and from thousands of individual molecules in parallel.
Oxford, UK - British techbio innovator Etcembly has launched a groundbreaking new research study aiming to uncover new targets for cancer therapies by analysing the immune cells of cancer survivors.
The ETCh study is recruiting people aged 18-65 who are living with or have survived cancer to join the study, as well as healthy volunteers. Participants will be asked to donate a small amount of blood up to five times over the course of one year, and provide information about their health.